Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management Carla Maria Boquimpani; André Neder Ramires Abdo; Denise Pires Martins; Luciana Britto de Abreu Lima; Mayde Seadi Torriani; Israel Bendit;

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;

Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel Elvira D. Rodrigues Pereira Velloso; Geórgia A. Padulla; Ana Maria Mósca de Cerqueira; Adriana Martins de Sousa; Alex Freire Sandes; Fabiola Traina; Fernanda Salles Seguro; Frederico Lisboa Nogueira; Grazielly de Fátima Pereira; José Laerte Boechat; Katia Borgia Barbosa Pagnano; Luan Lima Marchi; Luis Felipe Ensina; Mara Giavina-Bianchi; Marcelo Vivolo Aun; Rosana Câmara Agondi; Fabio Pires de Souza Santos; Pedro Giavina-Bianchi;